# Effects of Different Doses of Aspirin on Pathophysiological Markers in Type 2 Diabetes

> **NCT00898950** · NA · COMPLETED · sponsor: **University of Portsmouth** · enrollment: 21 (actual)

## Conditions studied

- Diabetes Type 2

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Aspirin
- **DRUG:** Aspirin
- **OTHER:** placebo tablet

## Key facts

- **NCT ID:** NCT00898950
- **Lead sponsor:** University of Portsmouth
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2009-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00898950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00898950, "Effects of Different Doses of Aspirin on Pathophysiological Markers in Type 2 Diabetes". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00898950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*